ANI Pharmaceuticals, Inc. (ANIP)
71.92
-1.33
(-1.82%)
USD |
NASDAQ |
Sep 01, 16:00
71.51
-0.41
(-0.57%)
Pre-Market: 08:44
ANI Pharmaceuticals Research and Development Expense (Annual) : 51.66M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 51.66M |
| December 31, 2024 | 44.58M |
| December 31, 2023 | 34.29M |
| December 31, 2022 | 22.32M |
| December 31, 2021 | 12.15M |
| December 31, 2020 | 27.26M |
| December 31, 2019 | 26.51M |
| December 31, 2018 | 14.05M |
| December 31, 2017 | 9.07M |
| December 31, 2016 | 2.906M |
| December 31, 2015 | 2.874M |
| December 31, 2014 | 2.678M |
| December 31, 2013 | 1.712M |
| December 31, 2012 | 15.96M |
| Date | Value |
|---|---|
| December 31, 2011 | 44.18M |
| December 31, 2010 | 39.71M |
| December 31, 2009 | 13.68M |
| December 31, 2008 | 15.79M |
| December 31, 2007 | 4.751M |
| December 31, 2006 | 3.856M |
| December 31, 2005 | 6.409M |
| December 31, 2004 | 9.162M |
| December 31, 2003 | 3.691M |
| December 31, 2002 | 4.787M |
| December 31, 2001 | 2.142M |
| December 31, 2000 | 1.888M |
| December 31, 1999 | 0.6606M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Viatris, Inc. | 952.50M |
| Liquidia Corp. | 38.45M |
| Elanco Animal Health, Inc. | 368.00M |
| Harmony Biosciences Holdings, Inc. | 189.59M |
| Corcept Therapeutics, Inc. | 254.91M |